Computational Tools for Mass Spectrometry Based Metabolic Profiling by Wegner, André
  
 
 
PhD-FSTC-2013-35 
 
The Faculty of Sciences 
 
 
DISSERTATION 
 
Presented on 12/12/2013 in Luxembourg  
 
to obtain the degree of 
  
 
DOCTEUR DE L’UNIVERSITÉ DU LUXEMBOURG 
 
EN BIOLOGIE 
 
by 
 
Andre WEGNER 
Born on 28 June 1982 in Berlin (Germany) 
 
COMPUTATIONAL TOOLS FOR MASS SPECTROMETRY 
BASED METABOLIC PROFILING 
 
 
Dissertation defense committee 
 
Dr Karsten Hiller, dissertation supervisor 
 Université du Luxembourg 
 
Dr Rudi Balling, Chairman 
Professor, Université du Luxembourg 
 
Dr Reinhard Schneider Vice Chairman 
Université du Luxembourg 
 
Dr Royston Goodacre 
Professor, University of Manchester 
 
 
 
Abstract
Within systems biology metabolomics emerged as an important field to study cellular
metabolism. The successful application of metabolomics techniques requires a close
interplay between experimental and computational approaches. In particular, stable
isotope assisted metabolomics methodologies require specialized algorithms to extract
biological information out of a metabolomics experiments. In this thesis the develop-
ment and application of novel mass spectrometry-based algorithms to analyze cellular
metabolism are presented.
First, the isotope cluster based matching (ICBM) algorithm was developed and imple-
mented as a c++ based library. The ICBM algorithm is a spectrum similarity measure
that is most efficient for the matching of compounds across different chromatograms.
Especially for non-targeted analyses, the ICBM algorithm outperforms the dot product
and other conventional tools. Moreover, the ICBM algorithm can be applied for an
efficient mass spectral library search.
Second, the ICBM algorithm was applied to characterize the metabolomes of the human
neuronal cell line LUHMES at low oxygen conditions (5%) compared to standard cell
culture conditions (20%). A difference at the metabolite level was observed when cells
were differentiated at 5% oxygen. Beside others, the major inhibitory neurotransmitter
in the mammalian central nervous system γ-aminobutyric acid (GABA) was found to
be increased at 5% oxygen.
Third, a methodology for the determination of chemical formulas and retained atoms
for mass spectral fragment ions was developed. This information about mass spectral
fragment ions is indispensable to extract more biological knowledge out of stable isotope
labeling experiments. Therefore, the fragment formula calculator (FFC) algorithm was
employed to determine the chemical formulas and retained carbon atoms of 160 mass
spectral fragment ions of central carbon metabolism.
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Chapter 1
Introduction
This chapter covers the followin publication [Wegner et al., 2012]:
Wegner, A.; Cordes, T.;Michelucci, A.; Hiller, K.
Current Biotechnology (2012), 1, 88-97
1.1 Metabolomics
In the postgenomic era, metabolomics has emerged as an important methodology within
systems biology and is defined as the analysis of the set of small molecule (or metabo-
lite) concentrations or amounts produced by a living organism. Although the concepts of
metabolomics was grounded more than 40 years ago, the first definition of metabolomics
was made by Oliver et al. in 1998 [Oliver et al., 1998]. Certainly, the analysis of
the metabolome complements the other three big “omics”, namely genomics, transcrip-
tomics and proteomics, but offers some unique advantages. Since metabolites are the
endproduct of the cell’s regulatory processes, the metabolome represents the cell’s final
phenotype. Hence it can be considered as the cell’s ultimate response to genetic or
environmental perturbations and therefore provides a closer functional link to an ob-
served phenotype [Villas-Boˆas et al., 2005]. In addition, the metabolome could reflect
extra-genomic effects caused by factors like the microbiome, which are not accessible
by transcriptomics or proteomics [Hunter, 2009]. As an example, it has been shown
that the microbiome has a large effect on the blood metabolome in mice [Wikoff et al.,
2009]. However, the metabolome is much more diverse than the genome or proteome
and consists of more than four (in the case of nucleic acids) or twenty (in the case of
proteins) unique building blocks. Compared to nucleic acids and proteins, the turnover
1
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rate of metabolites is more than two magnitudes higher and lies in the range of sec-
onds [Sellick et al., 2009a]. Therefore, accurate sampling of the metabolome requires
specific techniques, both for the extraction and measurement of metabolites. Current
methodologies for quantifying the metabolome typically rely either on nuclear magnetic
resonance spectroscopy (NMR) or mass spectrometry (MS) and analyze only the parts
of the metabolome which are defined by the methodology [Issaq et al., 2009, Macel et al.,
2010].
Generally, these analyses can be distinguished between targeted and non- targeted types.
While the first focuses on a set of known metabolites, the second approach tries to get
information about all known and unknown detectable metabolites. Although a non-
targeted approach provides information about more metabolites and is able to detect
changes in unexpected parts of the metabolome, absolute quantitative information can
only be obtained by a targeted approach [Hiller et al., 2011].
While metabolomics in its original form quantifies metabolite amounts or concentrations,
metabolic flux analysis (MFA) determines absolute values for metabolic conversion rates
or fluxes through the metabolic network [Haverkorn van Rijsewijk et al., 2011, Noguchi
et al., 2009]. These fluxes are dependent on metabolite concentrations and enzyme ac-
tivities. Due to the very targeted approach of MFA, its application is limited to known
parts of the metabolic network. As an extension, non-targeted stable isotope assisted
metabolomics methodologies have been developed. These non-targeted approaches allow
to obtain information about the metabolic fate of a labeled compound and can be the
starting point for the discovery of unknown or unexpected metabolic pathways [Hiller
et al., 2010, Kusmierz and Abramson, 1994, Sano et al., 1976].
1.1.1 Metabolomics Techniques
1.1.1.1 Sample Preparation
A typical metabolomics experiment can be divided in three key steps: sample prepara-
tion, analytical metabolite detection and computational data analysis. As the turnover
rate of metabolites lies in the range of seconds, a fast and effective quenching proce-
dure is necessary to immediately freeze all biochemical reactions of the cell. To prevent
leakage of intracellular metabolites the cell membrane should not be damaged by this
process. For this reason, the predominant quenching methods use an ice-cold methanol-
water or ethanol water mixture to abolish the tertiary structure of metabolic enzymes,
thereby stopping the metabolism [Spura et al., 2009, Villas-Boˆas et al., 2005]. A wide
range of protocols have been developed for the extraction and quenching of metabolites
for mammalian cells grown in suspension [Sellick et al., 2009b], for adherent mammalian
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cells, for body fluids (e.g. plasma , urine [Kind et al., 2007], cerebrospinal fluid (CSF)
[Wishart et al., 2008]) and for tissue [Wu et al., 2008]. The exact sample preparation
protocol not only depends on the biological sample, but also on the targeted metabolites
and the analytical technique [Lorenz et al., 2011].
1.1.1.2 Gas Chromatography Coupled To Mass Spectrometry
2
3 4 5
Vacuum Pump Data ProcessingGas Chromatograph
Sample injection
Gas
1
12345
Sample inlet
Interface between GC and MS
Source
Analyzer
Detector
Figure 1.1: GC/MS scheme
For most practical purposes, the two major analytical platforms for measuring metabo-
lite levels are MS [Lei et al., 2011] and NMR [Holmes, Nicholls, Lindon, Ramos, Spraul,
Neidig, Connor, Connelly, Damment, Haselden, and Nicholson, Holmes et al.]. Coupled
to a chromatographic separation technique like gas chromatography (GC)[Koek et al.,
2006] or liquid chromatography (LC) [Nordstro¨m et al., 2008, Want et al., 2005], MS of-
fers a much higher sensitivity compared to NMR. On the other hand, NMR yields specific
positional information, thus complementing the information gained by MS [Schroeder
et al., 2007]. Besides the classical GC and LC separation, ultra performance liquid
chromatography (UPLC) [Patterson et al., 2008] and capillary electrophoresis (CE) [La-
painis et al., 2009] are widely used. Since all algorithms and methods presented in this
thesis are optimized for GC/MS, I will focus on GC/MS here. Figure 1.1 depicts the
rough scheme of a GC/MS instrument. Such a device is composed of two major building
blocks: the GC and the MS. The GC separates compounds within a complex mixture
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and the MS then subsequently ionizes and detects the mass to charge ratios (m/z) of
those compounds. The most widespread ionization technique used in GC/MS is electron
M
M+
Sample 
Flow
e- e- e- e- e- e-
Electron 
Flow
Filament
Figure 1.2: Electron ionization source. Electrons are emitted by a heated filament
and accelerated towards a an anode by an appropriate potential. Typically, an energy
of 70 eV is used to generate a constant beam of electrons. When an electron hits a
neutral sample molecule, it knocks out one of its electrons, which induces vibrations,
rotations, and molecular rearrangements. As a result the molecule fragments.
ionization (EI), formerly called electron impact ionization. Figure 1.2 depicts the scheme
of an ion source. Compounds are exclusively ionized in the gas phase under vacuum to
form positive radical ions:
M + e− →M•+ + 2e− (1.1)
where M is a gaseous molecule, e− is the electron and M•+ is the resulting radical cation
of M (also called molecular ion). Since the resulting positive radical ion is highly unsta-
ble, in most cases it cannot be detected. However, EI creates reproducible fragmentation
patterns, which are characteristic for a given compound. The fragmentation of gas phase
ions is a complex and often hard-to-predict process. A detailed description can be found
elsewhere [McLafferty and Turecek, 1994]. Although the whole fragmentation process
can be very complex, there are only a few basic types of reactions that break or form
chemical bonds:
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Figure 1.3: Example of rearrangement after EI. Proposed fragmentation mecha-
nism of N ,O-bis-(trimethylsilyl)-glycine. After expulsion of a methyl radical by alpha-
cleavage next to the nitrogen, carbon monoxide loss occurs by a retro-Diels-Alder-like
reaction.
1. σ-ionization: Immediately breaks a bond (affecting mostly hydrocarbons)
2. α-cleavage: A new bond is formed from a radical site and an adjacent bond is
homolytically cleaved
3. Charge-induced heterolytic cleavage: Cleavage of a bond next to a charge-site
4. Rearrangements: Migrations of atoms or groups of atoms (Figure 1.3)
5. Displacement of atoms or groups of atoms
6. Eliminations
Once the compound molecules are ionized their mass to charge ratios are detected.
Figure 1.4 depicts a typical mass spectrum of one GC/MS fragment ion. These fragment
ions, also called isotope clusters, give rise to multiple peaks in the mass spectrum because
of naturally occurring stable isotopes. While, for example, 99% of the naturally occurring
carbons are 12C, 1% are 13C, creating these adjacent group of peaks in the mass spectrum
of a fragment ion. Every peak in a fragment’s mass spectrum corresponds to the same
elemental composition, but different isotopic composition. The mass spectrum of a
compound consists of several different isotope clusters, depending on the strength of
the fragmentation during the ionization process. In conclusion, a compound’s mass
spectrum is mainly determined by two things:
• The fragmentation after ionization
• The elemental composition of those fragment ions
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M+0 M+1 M+2 M+3 m/z
Intensity
Figure 1.4: GC/MS isotope cluster. In most cases, the highest peak within an ion
cluster originates from a straight combination of the lightest isotopes of all elements,
also called monoisotopic peak (M+0). In a given isotope cluster, all peaks are denoted
in the relationship of masses relative to the mass of the monoisotopic peak. For example,
the peak with one mass unit above the monoisotopic peak is denoted M+1. In case
of isotope clusters containing elements with a naturally high abundance of heavier
isotopes, such as chloride or bromide, the monoisotopic peak might not be the peak
with the highest intensity within the isotope cluster.
1.1.1.3 Derivatization
Most metabolites are not volatile enough to be analyzed directly by GC/MS. For that
reason, polar groups such as -CO, -COOH or -NH2 are chemically modified prior to anal-
ysis. There exist a wide range of derivatization agents, however silyl derivatives are suited
best for GC/MS analysis. In this thesis I used mainly N -Methyl-N -(trimethylsilyl)-
trifluoracetamide (MSTFA) which creates the typical trimethylsilyl (TMS) derivatives
andN -(tert-butyldimethylsilyl)-N -methyltrifluoroacetamide (MTBSTFA) which creates
the typical tert-butyldimethylsilyl (TBDMS) derivatives (Figure 1.5).
1.1.2 Methods Of Compound Identification
One of the advantages of GC/MS and electron ionization is relatively easy compound
identification (compared to e.g. LC/MS), because electron ionization generates repro-
ducible and characteristic mass spectra. These mass spectra can be collected and stored
in a reference library, which can then be used to identify compounds of GC/MS measure-
ments. To do this, a spectrum similarity score between the mass spectrum of a measured
compound (Smes) and all mass spectra in the reference library (Slib) is calculated. The
library compound with the highest spectrum similarity score is then assigned to the
measured compound. Additionally, a score based on the retention time can be calcu-
lated to discriminate compounds that have highly similar mass spectra. Usually, both
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Figure 1.5: Schematic of GC/MS derivatization. Hydrogens of polar groups
that are substituted either by a trimethylsilyl (TMS) group or a tert-butyldimethylsilyl
(TBDMS) group are shown in red. A wide range of organic compounds can be easily
derivatized to their respective TMS and TBDMS derivatives, which has the advantage
that silyl derivatives are generally less polar, more volatile and thermally more stable
than their precursors.
scores are applied to align compounds of a batch of chromatograms in a metabolomics
experiment.
1.1.2.1 Spectrum Similarity Score
In the past decades several spectrum similarity based identification algorithms have been
developed. Of these the weighted dot product has proven to perform best in terms of
accuracy [Stein and Scott, 1994]. A compound’s mass spectrum S is defined as a set of
pairs of masses and intensities:
S = (m1, i1) = p1, (m2, i2) = p2, ..., (mn, in) = pn
mi < mi+1 i ∈ N
(1.2)
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According to Stein and Scott, each mass intensity pair pi of both the measured and
reference spectrum is weighted according to the following rule:
pw = [mass]a × [intensity]b (1.3)
where a and b are the weighting factors that represent the contribution of the m/z value
and the peak intensity, respectively. Stein and Scott reported that the optimal values are
b = 0.6 for intensity scaling and a = 3 for mass weighting [Stein and Scott, 1994]. This
way, the relative influence of minor intensities at higher masses is increased. However,
several different values have been proposed to be the optimal weighting factors over
the last years. Recently, Kim et al. showed that weighting factors should be chosen
individually based on the reference library used [Kim et al., 2012].
We denote a set of weighting factors as w=(a,b). The dot product of the library (Swlib)
and measured (Swmes) spectrum is then calculated as follows:
ScoreSpecDot =
Swlib × Swmes
||Swlib|| ||Swmes||
(1.4)
As a result, the spectrum similarity score is located within the interval zero (no identity)
to one (identical spectra).
1.1.2.2 Retention Index Similarity Score
Because the retention time is dependent on the instrument used, the GC-capillary, or
the applied temperature program, etc., we use the Kovats [Kovats, 1958] retention index
(RI) for all retention time-based similarity measures. Assuming that the determined
retention indices for a certain compound are distributed in a Gaussian manner across
different chromatograms, a Gaussian function is used for the RI based similarity index
calculation:
ScoreRI = e
− (rilib−rimes)
2
2x2 (1.5)
1.1.2.3 Chromatogram Alignment
If a number of GC/MS chromatograms are to be analyzed comparatively, it is necessary
to align similar compounds among the different chromatograms. To additionally account
for the retention time of a compound, a combined similarity score Scoretotal based on
the spectrum and retention index similarity is calculated. Because the spectral profile of
a compound contains more information than the retention index, it is weighted stronger
Scoretotal =
3
√
Score2spec · ScoreRI (1.6)
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1.1.3 Targeted vs Non-Targeted Metabolomics
Although metabolism was extensively studied over the last decade and many path-
ways and their respective metabolites have been uncovered, the assumption that this
knowledge is complete is probably false, especially for disease specific alterations of
metabolism. However, a targeted approach relies partially on this assumption, because
it only takes a predefined set of metabolites into consideration. Apparently, this set does
not include unknown metabolites but can include metabolites not known to be produced
by a specific organism or under a specific condition. A non-targeted approach, however,
tries to analyze all measurable metabolites. As such, a non-targeted approach is able to
capture metabolites not yet known or not known to be produced by a specific organism
or under a specific condition. The advantage of a targeted approach is that it can ob-
tain absolute quantitative information. For that reason a non-targeted approach cannot
replace a targeted approach, but can yield additional information that is disguised by a
targeted approach. To obtain a more comprehensive view of cellular metabolism, both
techniques should be combined, with the targeted approach being preceded by the non
targeted approach. This way the non targeted approach works as a discovery tool to
better constrain the targeted analysis.
1.2 Stable Isotope Assisted Metabolomics
The above described technologies provide a tool set to conduct metabolomics research.
Although they can detect changes in metabolite concentrations, no information about
increases or decreases of fluxes in the associated pathways can be obtained. However,
metabolic fluxes reflect the quantitative endpoint of the interplay between gene expres-
sion, protein synthesis, post-translational modifications and thermodynamic constraints,
therefore representing the cell’s final phenotype. Analyzing intracellular metabolic fluxes
is essential investigating the physiological state of a cell and thereby revealing disease
specific alterations or dysregulations of metabolic conversion rates and enzyme activi-
ties. As a consequence of the complex regulation of metabolic pathways, significant flux
changes are sometimes associated only with a modest change in metabolite concentra-
tions [Fell, 2005]. To obtain information about intracellular dynamics, stable isotope
labeled components can be applied. For that, stable isotope (e.g. 13C, 15N) labeled
substrates (e.g. glucose, glutamine) are fed to the target system (e.g. cell culture, tis-
sue, whole organism) until cellular metabolism distributes the isotopes throughout the
metabolic network. Based on the reaction rates and enzyme activities present in the sys-
tem, distinct labeling patterns will arise affecting the molecular weight of the fragment
ions.
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1.2.1 Mass Isotopomer Distribution
Using an MS approach, fragment ions are separated according to their m/z ratio. Based
on the incorporated labeled atoms, the m/z ratio is shifted by one or more atomic mass
units, resulting in different shifted mass spectra. According to the international union of
pure and applied chemistry (IUPAC), an isotopomer is defined as an isomer having the
same number of each isotopic atom but differing in their positions. On the other hand,
an isotopologue is defined as a molecular entity that differs only in isotopic composition
(number of isotopic substitutions). Within the metabolic community the term mass
isotopomer is used as a synonym for isotopologue. The number of isotopomers (2n) is
therefore always larger than the number of mass isotopomers or isotopologues (n+1),
where n is the number of possible isotopic substitutions (Figure 1.6). Based on the MS
measurement, mass isotopomer distributions (MIDs) as the relative amount of each mass
isotopomer can be calculated by solving a linear equation system [Lee et al., 1991]. In
order to set-up the equation system and to calculate correct MIDs, a correction matrix
is needed that corrects the MIDs for naturally occurring stable isotopes. Figure 1.6b
depicts the correction matrix for a two carbon compound. The first column corresponds
to the natural mass isotopomer distribution of the unlabeled compound (M00, M01 and
M02 in Figure 1.6). The second column corresponds to the natural mass isotopomer
distribution if one of the 12C is replaced with a 13C (M10, M11 and M12 in Figure 1.6).
The third column corresponds to the natural mass isotopomer distribution if both of the
12C are replaced with a 13C (M20, M21 and M22 in Figure 1.6). This correction matrix
can be setup by predicting the mass spectrum of the tracer using multinomial expansion
based on the natural abundance of stable isotopes along with the chemical formula of the
fragment ion. If the chemical formula of the fragment ion is not known, the unlabeled
reference spectrum of the fragment ion can be applied [Jennings and Matthews, 2005]. In
addition to static metabolite concentrations, MIDs provide dynamic information about
how a compound is metabolized within the cell. This includes the involved pathway(s),
enzyme activities and the fate of the labeled atoms (assuming the respective pathway
intermediates can be measured). The importance of measuring MIDs is best explained
by a short example: Glucose can be metabolized to pyruvate either via glycolysis or the
pentose phosphate pathway (PPP). Depending on the respective pathway the carbon-
carbon bonds of glucose are broken and rearranged specifically. If glucose is metabolized
via the PPP, the first carbon atom is decarboxcylated in the oxidative phase, whereas
it is conserved in glycolysis (Figure 1.7). As a consequence, the relative amount of
glucose metabolized through the PPP compared to glycolysis can be revealed by using
a glucose tracer labeled on the first and second carbon atoms (1,2-13C2 glucose). The
MID of pyruvate gives direct information of the metabolic flux of glucose through the
two pathways. Pyruvate containing one stable carbon isotope (M1) was metabolized via
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Figure 1.6: Mass isotopomer distribution (MID). (a) Based on the number and posi-
tion of incorporated labeled atoms, different isotopomers are shown (12C in black, 13C
in red). The mass spectrum is depicted along with the corresponding mass isotopomer.
(b) In reality only one mass spectrum is measured for a complex mixture of mass iso-
topomers and the fraction of each mass isotopomer has to be determined by solving the
linear equation system. In this case 50% of the molecules are unlabeled, 25% contain
one stable isotope and 25% contain two stable isotopes (Figure based on [Hiller et al.,
2011])
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Glucose
Glucose-6-phosphate Ribulose-5-phosphate
Pyruvate
Figure 1.7: Simplified scheme of the pentose phosphate pathway and glycol-
ysis. The carbon backbones of every metabolite is shown in circles (12C in white and
13C in red). Since the first carbon atom originating from glucose is decarboxylated in
the oxidative phase of the pentose phosphate pathway (PPP), whereas it is conserved
in glycolysis, the number of 13C atoms in Pyruvate yield information about the activity
of the two pathways. Pyruvate containing one 13C atom was metabolized via PPP and
pyruvate containing two 13C atoms via glycolysis.
PPP and pyruvate labeled by two stable isotopes (M2) via glycolysis. The ratio of M1
and M2 mass isotopomers represent the respective flux through PPP and glycolysis.
1.3 Metabolic Flux Analysis
MFA aims to quantify all intracellular fluxes in a given system. Initial methods were
based solely on a known stoichiometry of the biochemical reaction network of interest
[Stephanopoulos, 1999, Varma and Palsson, 1994]. In that context, intracellular fluxes
can be inferred by measuring the metabolic input and output under the assumption of
a metabolic steady-state. An example for a very simple reaction network is depicted
in Figure 1.8a. In total this reaction network has 5 fluxes. The steady-state constraint
yields the following flux relations:
u = v + w v = x w = y (1.7)
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If the extracellular fluxes u and x are measured, then the fluxes v, w and y can be
calculated using the following equations:
v = x w = u− x y = u− x (1.8)
However, in living cells intracellular metabolism is much more complex than illustrated
in the example. Particularly, stoichiometric MFA fails in the following situations:
bidirectional reaction steps and certain parallel or cycle reactions [Wiechert, 2001a].
Figure 1.8b depicts the same reaction network, but with one additional reaction r. For
this reaction network intracellular fluxes cannot be inferred from measuring the extra-
cellular fluxes alone. To overcome these limitations more sophisticated methods such as
13C-MFA evolved.
Figure 1.9 depicts an overview of the experimental and computational steps necessary
to perform 13C-MFA. The first important step is to select a suitable isotopic tracer. The
precursor and the position of the label should be chosen carefully, because this heavily
influences the precision and accuracy of the flux estimation. For the example illustrated
in Figure 1.8b, only a label on the third or fourth carbon atom yields additional in-
formation in which case the flux r can be determined by the percentage of the labeled
carbons in metabolite B. A recent study evaluated different 13C tracers for their use in
13C-MFA experiments [Metallo et al., 2009]. For example, the 1,2-13C2-Glucose tracer
is suited best to study the PPP and glycolysis, whereas 1-13C-glutamine is suited best
to study the reductive flux from α-ketoglutarate to citrate. The second important step
is to create a metabolic network model that defines the metabolic reactions and atom
transitions for the pathway of interest. Once the isotopic tracer and the metabolic net-
work model are defined, a stable isotope labeling experiment is performed. For that,
13C-labeled precursors are introduced into the network. The redistribution of the label
into other metabolites is measured after the system reaches an isotopic and metabolic
steady-state assuming constant intracellular fluxes and labeling patterns. The labeling
patterns or MIDs can then be detected either by mass spectrometry or NMR. Since
intracellular fluxes cannot be measured directly, 13C-MFA estimates the cell’s flux state
based on measured MIDs. For that, an iterative non linear least squares fitting proce-
dure is applied to find a set of fluxes that account best for the observed MIDs [Wiechert,
2001b]. In order to do that, a mathematical model is required that can simulate MIDs
for a given set of steady state fluxes.
During the last years, several different approaches have been developed to mathemati-
cally describe the relation between MIDs and the corresponding fluxes. Schmidt et al.
used a matrix approach [Schmidt et al., 1997] to generate a complete set of isotopomer
balances, based on the idea of atom-mapping matrices (AMM) [Zupke and Stephanopou-
los, 1994]. Generalizing the concept of AMMs, which track the transfer of carbon atoms
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Figure 1.8: (a) A simple example network, where intracellular fluxes can be calculated
with stoichiometric MFA as shown in the text. (b) The same reaction with one addi-
tional intracellular reaction r. The carbon transitions are shown for every compound
(12C in white and 13C in black). Based on the carbon transition network the flow of
label from compound A can be traced to the metabolites B and C to infer the flux r.
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Figure 1.9: MFA overview
from reactants to products, Schmidt introduced isotopomer mapping matrices (IMMs).
In this case, isotopomer distribution vectors (IDVs) are generated for each metabolite,
which contain the molar fraction of each isotopomer. IMMs are then used to sum up the
fraction of each reactant isotopomer that form a respective product isotopomer (Figure
1.10). Later, Wiechert et al. further extended this idea and introduced the concept of
cumulative isotopomers (cumomers) [Wiechert et al., 1999]. Cumomers balances can
be calculated computationally more efficient than isotopomer balances [Wiechert et al.,
1999], but they do not reduce the size of the problem meaning that there are always
as many cumomer balances as there are isotopomer balances. To overcome this limita-
tion, Antoniewicz et al. developed the elementary metabolite unit (EMU) framework
[Antoniewicz et al., 2007]. Here, the minimal amount of information is calculated fully
describing the measured labeling states. The authors claim that the number of variables
are an order of magnitude smaller compared to the previously described techniques. It
is important to note that the size of the defined metabolic network is a critical factor
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Figure 1.10: (a) A simple reaction network model used as an example to create an
atom mapping matrix (AMM) and an isotopomer matrix (IMM). The network contains
one reaction v1. (b) Atom transition network, describing the carbon atom transitions
from compound A to B occurring in reaction v1. (c) Atom mapping matrix and metabo-
lite vector that describes the reaction network and atom transitions. (d) Isotopomer
mapping matrix that converts the isotopomer distribution vector of compound A to the
isotopomer distribution vector of compound B. The possible isotopomers are shown in
circles (12C in white and 13C in black) with the corresponding binary code.
Chapter 1. Introduction 17
in 13C-MFA. As the network increases in size, more constraints (measured MIDs) are
needed to perform 13C-MFA. On the other hand, a small network may be not able to
capture the complex metabolic network present in living cells. In Chapter 3, I will intro-
duce a novel algorithm that helps to incorporate more constraints and with it a bigger
metabolic network to perform 13C-MFA.
Initially, MIDs were derived by only measuring proteogenic amino acids [Zamboni et al.,
2009]. However, the time for biomass to reach an isotopic steady-state is at least one
cell generation time [Wiechert and No¨h, 2005]. Hence, a long and cost-intensive exper-
imental duration is necessary. A more direct and intuitive way is to directly measure
MIDs for intracellular pathway intermediates of interest, though, this is challenging for
two reasons: First, the concentrations of intermediates in central carbon metabolism
are usually very low. Second, the metabolic turnover rates can be very high. However,
recent technological improvements in sample preparation and mass spectrometry have
partly overcome these limitations and allow accurate determination of MIDs for many
intracellular metabolites [Antoniewicz et al., 2007].
13C-MFA has been applied to calculate fluxes in various systems, such as bacteria, yeast,
plants and mammalian cells [Marin et al., 2004, Masakapalli et al., 2010, Niklas and Hein-
zle, 2012, Niklas et al., 2010, Raghevendran et al., 2004].
Citrate
Isocitrate
Succinyl-CoA
Succinate
Fumerate
Malate
Oxaloacetate
-ketoglutarateα
Acetyl-CoA
Glutamate
Figure 1.11: Simplified TCA cycle to demonstrate the value of stable iso-
topes. The carbon backbones are shown in red for 13C and in black for 12C. By
following the isotopic labeled atoms of glutamate the reversibility of the reactions con-
verting α-ketoglutarate to citrate becomes clear. Moreover, the reductive flux from
α-ketoglutarate to citrate can be calculated.
In summary, stable isotopes can add value to metabolomics studies in two ways: (i)
Stable isotopes can reveal unanticipated reactions that are currently not known or not
associated for a given metabolic state. (ii) Stable isotopes can be used to calculate
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absolute values for intracellular fluxes. The network in Figure 1.11 illustrates a simplified
version of the TCA cycle. The reductive and oxidative flux from α-ketoglutarate to
citrate cannot be distinguished by only measuring the metabolite concentrations of e.g.
citrate, but can be inferred from the MIDs.
1.4 Aim And Outline Of Thesis
In the emergent field of systems biology metabolomics has become a key player. Specifi-
cally, non-targeted metabolomics methodologies have proven to be indispensable. Recent
technological improvements in sample preparation and mass spectrometry have provided
the means to detect an increasing number of intracellular metabolites. However, the
ability to extract biological knowledge out of these data mainly relies on the applied
computational analysis. For that reason, novel algorithms have to be developed to ob-
tain more biological knowledge out of the flood of metabolomics data. Moreover, the
appropriate software tools have to be developed to facilitate the use of these algorithms
within the metabolomics community.
• Chapter 2 describes the development and application of non-targeted metabolomics
methodologies. First, an alternative spectrum similarity measure that is based on
the specific fragmentation patterns of electron impact mass spectra is presented.
I developed the isotope cluster based compound matching (ICBM) to overcome
the problem of mismatched compounds typically occurring during chromatogram
alignment. The ICBM algorithm allows a sensitive peak detection step without
losing the specificity of the compound matching. As such, the algorithm is most ef-
ficient for the alignment of compounds across different chromatograms. Specifically
for non-targeted analyses, the ICBM algorithm outperforms conventional tools as
for example the dot product. Moreover, this chapter includes the application of the
ICBM algorithm to characterize the metabolome of the human mesencephalic cell
line (LUHMES, Lund human mesencephalic) [Scholz et al., 2011] under different
oxygen conditions.
• Chapter 3 describes a methodology for the determination of chemical formulas
and retained atoms for mass spectral fragment ions. Chemical formulas usually
form the basis of MID calculations for specific ions. Hence, the correct assignment
of chemical formulas to fragment ions is of crucial importance for the calculation
of accurate MIDs. Furthermore, the retained carbon atoms of fragment ions are
necessary to perform 13C-MFA. However, the process of mass spectral fragmen-
tation is complex and assigning chemical formulas and retained atoms to mass
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spectral ions is non-trivial. To address this shortcoming, I developed an approach,
based on a systematic bond cleavage, to determine chemical formulas and the re-
tained atoms for GC/MS fragment ions. I applied the fragment formula calculator
(FFC) to determine the chemical formulas for a wide range of TMS and TBDMS
derivatized fragment ions.
Chapter 2
Non-Targeted Metabolomics
Methodologies
This chapter covers my contributions to publications about non-targeted metabolomics
methodologies. This includes the spectrum similarity measure “Isotope Cluster-Based
Compound Matching” and a new software tool for the non-targeted detection of stable
isotope labeled compounds. As an example to point out the importance of non-targeted
metabolomics methodologies, I will discuss the discovery of the previously unknown link
between immunoresponsive gene 1 (Irg1 ) and itaconic acid. The main results are summa-
rized with respective cross references to already published articles. For methodological
details, please consult the corresponding manuscript [Hiller et al., 2013, Michelucci et al.,
2013, Wegner et al., 2013].
Wegner, A.; Sapcariu, S. C.; Weindl, D.; Hiller, K.
Analytical chemistry (2013), 85(8), 4030-4037
Hiller, K.; Wegner, A., Weindl, D.; Cordes,T.;
Metallo, C. M.; Kelleher, J. K.; Stephanopoulos, G.
Bioinformatics (2013), 29(9), 1226-8
Michelucci, A.; Cordes, T.; Ghelfi, J.; Pailot, A.;
Reiling, Npublication given in appendix.; Goldmann, O.; Binz,T.; Wegner, A.;
Tallam, A.; Rausell, A.; Buttini, M.; Linster, C.;
Medina, E.; Balling,R.; Hiller, K.
PNAS (2013), 110(19), 7820-7825
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Figure 2.1: Example of a spectrum similarity score calculated with the
dot product. The measured spectrum is shown in blue in the positive direction
and the matched spectrum of the library is shown in red in the negative direction.
The library spectrum obviously does not match the library spectrum. However, the
spectrum similarity score calculated with the dot product is 0.9, which is relatively
high. One reason for the high score is the fact that single peaks at higher masses have
a bigger influence on the final spectrum similarity score compared to peaks at lower
masses. The peak at mass 420 in the measured spectrum dominates the final spectrum
similarity score, which leads to a false positive identification.
2.1 Isotope Cluster Based Compound Matching
A typical comparative metabolomics analysis (both targeted and non-targeted) consists
of three steps: First, compounds (clusters of ion-chromatographic peaks) are detected
in every measured chromatogram. Second, detected compounds are matched across
all chromatograms (chromatogram alignment) and quantitative values are calculated.
Third, matched quantitative values are statistically analyzed (e.g. principal compo-
nent analysis, self-organizing maps, etc.). While in the beginning metabolomics studies
mainly focused on the quantification of a targeted set of previously known metabolites,
recent studies have tried to quantify all detectable metabolite peaks within a chro-
matogram. This non-targeted approach, however, generates a bottleneck already at
the first step of analysis. Metabolites of low concentration will be hard to distinguish
from “noise peaks” (usually small peaks near the GC baseline) in the compound detec-
tion step. The more sensitive the peak detection step, the more erroneously detected
compounds are present in the data set, making it more difficult to match “real” chro-
matographic peaks across different samples. On the other hand, “real” chromatographic
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peaks might be overlooked when less sensitive settings are applied. Finding the right
tradeoff between sensitivity and specificity for the compound detection can be challeng-
ing. For a targeted approach, compounds of interest are known in advance, and optimal
compound-specific settings can be determined by evaluating the results for these com-
pounds. However, in a non-targeted methodology, such evaluation is not possible, and
compounds of interest might be inadvertently removed when less sensitive compound
detection settings are applied. Therefore, settings with a high sensitivity should be ap-
plied in these cases.
Current spectrum-matching-based identification algorithms, such as the dot-product,
struggle with data generated by non-targeted metabolomics experiments, when a highly
sensitive compound detection step was applied. One major problem of the dot-product
is that, due to the applied scaling algorithm, single peaks at higher masses can falsify
the spectrum similarity score which leads to wrongly assigned compounds in the chro-
matogram alignment step (see Figure 2.1). Consequently, quantitative values for these
mismatched compounds are calculated incorrectly which may conceal an important re-
sult or dissembles a wrong result of this experiment. To overcome this limitation I have
developed the isotope cluster based compound matching (ICBM) algorithm [Wegner
et al., 2013].
The ICBM algorithm places a higher emphasis on the specific fragmentation pattern
of EI mass spectra and takes into account the natural stable isotope abundances. The
fragmentation pattern and the distribution of natural stable isotopes are the two most
characteristic features of EI mass spectra and are, therefore, well suited to discriminate
between different mass spectra. The isotope cluster based matching algorithm consists
of four main steps (Figure 2.2):
1. All mass spectral isotope clusters are determined for the measured and the refer-
ence spectrum respectively.
2. Isotope clusters are aligned based on the m/z values of their monoisotopic peaks.
3. Two similarity scores are calculated. For isotope clusters with matching monoiso-
topic peaks, a score based on the isotope cluster’s peak ratios is calculated. For
non-matching isotope clusters and non-grouped peaks, a score based on the dot
product is calculated.
4. The two similarity scores are combined to a final score between 0 and 1, where 1
represents a perfect match and 0 a mismatch between the query and the reference
spectrum.
In contrast to the dot product, the ICBM algorithm focuses more on those features of a
compound’s mass spectrum that are characteristic for the compound. In this light, the
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Figure 2.2: Overview of the ICBM algorithm. (A) Detected isotope clusters of
the measured spectrum are colored in green and of the library in red. (B) Detected
isotope clusters are aligned based on the masses of their monoisotopic peaks. Two
isotope clusters are considered a match if the mass of their monoisotopic peak is identical
(shown in bold). After, the alignment the peaks of both spectra are divided in two
separate subsets. Peaks of identical isotope clusters are shown in blue, and peaks of
non-matching isotope clusters or not grouped within a fragment in orange. (C) Two
similarity scores based on the fragment alignment are calculated and combined.
ICBM algorithm works in part analogous to a manual inspection of the mass spectrum
by an expert.
2.1.1 Mathematical Description Of The ICBM Algorithm
I define an ion cluster as a subset of a spectrum S:
f = {pk, ..., pl}, 0 < k < l ≤ n, f ⊂ S (2.1)
where pk denotes the first peak and pl the last peak of the ion cluster. A spectrum
S can have multiple ion clusters, which are all disjointed subsets of S. As a reference
point within an ion cluster, I use the peak with the highest intensity (IM ). I will use
the term isotope cluster normalization to refer to the ratio ri of each isotope cluster’s
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peak intensity in relation to the intensity of its peak IM :
ri =
IM+i
IM
k ≤ i ≤ l (2.2)
2.1.1.1 Isotope Cluster Determination
The algorithm for the isotope cluster detection iterates through S once. All consecutive
peaks with a mass difference of one unit and decreasing intensities are grouped together
into separate isotope clusters:
mj −mj+1 = −1 ∧ IMj > IMj+1 (2.3)
In case of overlapping isotope clusters or an isotope cluster containing elements with a
high abundance of natural stable isotopes such as chlorine or bromine, the algorithm
splits them into two separate isotope clusters.
2.1.1.2 Isotope Cluster Alignment
Isotope clusters of the measured spectrum are aligned to the isotope cluster of the
library spectrum based on the mass of their monoisotopic peaks (Figure 2.2b). Two
isotope clusters are considered a match if the masses of their monoisotopic peaks are
identical. In case of a peak at mass mi present in one isotope cluster but not in its
counterpart, a peak of mass mi and intensity 0 is added to the corresponding isotope
cluster. This way, aligned isotope clusters always have the same number of peaks. The
measured and the library spectra can then be divided into two subsets of peaks. One
set contains all peaks from the matching isotope clusters (F), and the other contains the
remaining peaks of the spectrum (R).
F ∪R = S (2.4)
In the illustrated example, peaks of the set F are highlighted in blue and peaks of the
set R in orange (Figure 2.2b).
2.1.1.3 Similarity Score Calculation
On the basis of the alignment, one score is calculated for set F (matched isotope clusters)
and one score for R (non-matching isotope clusters and peaks not grouped within an
isotope cluster) (Figure 2.2c). First, for each matched isotope cluster in F, all peak
intensities are normalized by the respective monoisotopic peak. Second, the distance
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d between two isotope clusters is calculated by summing the absolute values of the
differences between corresponding normalized peak intensities:
d =
n∑
i=0
|rlibi − rmesi | (2.5)
To keep the score within the interval [0,1], the contribution of one isotope cluster pair
to the total similarity score is weighted by the number of isotope cluster peaks and an
intensity scale. Therefore, the isotope cluster’s summed intensity is divided by the total
intensity of the mass spectrum to obtain the intensity fraction of the isotope cluster in
S:
x = number of peaks within f
intensity scale =
Ifmes
ISmes
+
Iflib
ISlib
scale = intensity scale · x
(2.6)
The total isotope cluster-based distance of the two mass spectra is then calculated as
follows:
ScoreF =
1
n
·
n∑
i=0
di · scalei (2.7)
where n is the number of matched isotope clusters. This calculation transforms the
distance in the interval between zero (identical spectra) to one (no identity). To make
this score comparable to the score of the dot product, ScoreF is inverted within the
interval [0,1]:
ScoreF = 1− ScoreF (2.8)
For the remaining peak set R, a similarity score based on the dot product (see equation
1.4) is calculated. These two similarity measures are then combined to form a composite
spectrum similarity score. To reduce the bias to favor one of the two scores, a weighting
factor wF based on the summed intensities of all matched isotope clusters is calculated:
wF = (
IFmes
ISmes
+
IFlib
ISlib
) · 1
2
(2.9)
When for example the summed intensity of all matched isotope clusters encompasses
70% of the total intensity of the measured and the library spectrum, the isotope cluster-
based score is weighted with 0.7 and the dot product score with 0.3. The final spectrum
similarity score is then calculated as follows:
ScoreSpecIC = (1− wF ) · ScoreSpecDot · wF · ScoreF (2.10)
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2.1.2 Applications Of The ICBM Algorithm
The ICBM algorithm is most efficient for a non-targeted chromatogram alignment, which
has the advantage that metabolites not present in a reference library will pop up in
the analysis result as unidentified metabolites. As such, a non-targeted chromatogram
alignment is able to capture metabolites not yet known or not known to be produced
by a specific organism or under a specific condition. In case an unidentified metabolite
pops up in the analysis, there exist several strategies that can be used to identify these
compounds. One could use a different measurement technique, such as LC/MS, to infer
a chemical formula or NMR to gain structural knowledge. A more straightforward way
is to use a bigger reference library for the identification step. This assumes, however,
that the unidentified metabolite was annotated previously. The most comprehensive
EI mass spectral reference library is maintained by the National Institute of Standards
and Technology (NIST) and comprises 243,893 reference spectra of of 212,961 unique
compounds. Unfortunately, the provided NIST MS search software is only available for
windows operating systems and does not provide a relatively simple integration into third
party software. Currently, our group uses an in-house reference library containing around
400 reference spectra, which covers the most important parts of metabolism, but is
certainly not extensive enough. For that reason we acquired the NIST08 reference library
in ASCII text format to utilize it within the MetaboliteDetector software package [Hiller
et al., 2009]. However, within MetaboliteDetector the target spectrum is compared to
all spectra within the reference library for identification. If the computational time for
Figure 2.3: MetaboliteDetector library search
one spectrum comparison is 1ms then one identification using the NIST library within
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MetaboliteDetector would take around 240s. For a typical metabolomics experiment
with more than 500 metabolites the computation time will be around 33h which makes
it inconvenient for most practical purposes. One way to reduce the computational time
of one identification is to compare the target spectrum only to a subset of the reference
library. This subset can be generated with the ICBM algorithm. The overall steps are
as follows:
• Preprocessing
– Determine isotope clusters of all spectra within the reference library
– Store m/z of monoisotopic peak of the five most abundant isotope clusters
• Generate list of possible matches
– Determine isotope clusters of target spectrum
– Find all spectra within the reference library that have at least x (e.g. 5) of
the isotope clusters (matching m/z value of the monoisotopic peak)
• Find best match
– Calculate spectrum similarity score to each spectrum in the list of possible
matches
The total number of comparisons is reduced significantly by using the strategy described
above. To take advantage of the library search functionality, I implemented this feature
as well as the ICBM algorithm in the current version of the MetaboliteDetector. Cur-
rently, a mass spectral library in NIST format can be imported to an SQLite database.
This database can then be queried for selected compounds within MetaboliteDetector’s
graphical user interface. Figure 2.3 depicts the search result for tyrosine 3-TMS with
the NIST08 as the underlying reference library.
The advantage of utilizing a big reference library such as the NIST library became ap-
parent for a discovery made recently in our institute. In a non targeted metabolomics
experiment we found highly elevated levels of itaconic acid in LPS treated macrophages
compared to non-treated macrophages. Since itaconic acid was not known to be pro-
duced by mammalian cells, it was not present in our reference library. Nevertheless, it
popped up as one of the unidentified compounds in our non-targeted analysis. In fact,
it was one of the most significantly changed metabolites [Michelucci et al., 2013]. The
application of the above described ICBM library search functionality helped to iden-
tify this compound as itaconic acid. (Figure 2.4). For itaconic acid the m/z values of
the monoisotopic peaks of the 5 most abundant isotope clusters are: 147 m/z, 73 m/z,
215 m/z, 259 m/z, and 97 m/z. The NIST08 spectral library contains roughly 200,000
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Ethyltrimethylsilyl dipropylmalonate
1-Cyclopentene-3,5-dione, 4-hydroxy-1,2,4-tris(trimethylsilyloxy)-
2-Pentenedioic acid, bis(trimethylsilyl) ester
Butanedioicacid, methylene-, bis(trimethylsilyl) ester
Mesaconic acid, bis(trimethylsilyl) ester
Methylmaleic acid, bis(trimethylsilyl) ester
D-Ribonic acid, 2,3,5-tris-O-(trimethylsilyl)-, .gamma.-lactone
2-Ethylacetoacetate, O,O'-bis(trimethylsilyl)-
Octadecanoic acid, 9,10-bis[(trimethylsilyl)oxy]-, methyl ester
Bis(trimethylsilyl)-2-Methyl-2,4-bis(trimethylsilyloxy)glutarate
Octadecanoic acid, 9,10-bis[(trimethylsilyl)oxy]-, methyl ester, (R*,S*)-
2-Ethyl-3-ketohexanoate, bis(O-trimethylsilyl)-
1,2,2,3,3,4,5,5,6,6-Decamethyl-7-oxa-1,2,3,4,5,6-hexasila-bicyclo[2.2.1]heptane
7-Dimethyl(trimethylsilylmethyl)silyloxytridecane
Pentanoic acid, 4-methyl-2-oxo-, bis(trimethylsilyl) deriv.
Trimethylsilyl (2Z)-4-methyl-2-[(trimethylsilyl)oxy]pent-2-enoate
Di-n-propylmalonic acid, bis(trimethylsilyl) ester
1H-Indole-2,3-dione, 5-tert-butyl-1-(trimethylsilyl)-, 3-[O-(trimethylsilyl)oxime]
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Figure 2.4: Overview of ICBM library search. 1) Determination of isotope
clusters of the measured spectrum. In the case of itaconic acid the m/z values of the
monoisotopic peak of the five most abundant isotope clusters are: 147 m/z, 73 m/z,
215 m/z, 259 m/z, and 97 m/z. 2) The library is queried for the m/z values of the five
most abundant isotope cluster determined in the previous step. A list of possible hits is
generated, including all compounds that have at least 3 of the queried isotope clusters.
3) A spectrum similarity score is calculated for all compounds in the possible hit list.
4) The entry with the highest spectrum similarity score is assigned to the measured
compound
EI mass spectra. The list of possible hits, however, generated with the above stated
isotope clusters only contains 19 mass spectra (see Figure 2.4). Although the isotope
clusters at 147 m/z and 73 m/z originate from the derivatization reagent and usually
do not carry any discriminating information, in case of big reference libraries containing
mass spectra of different derivatization reagents, they help to highlight the correct com-
pounds. It should be noted that the itaconic acid could have been also identified with a
different library search program (e.g. with NIST MS search software). Nevertheless, the
integration of the ICBM library search functionality eminently improves the usability of
MetaboliteDetector.
In summary, the ICBM algorithm improves a non-targeted metabolomics experiment in
two ways: First, it improves the alignment of compounds across different chromatograms,
which is one of the main bottlenecks of a non-targeted metabolomics analysis. Second,
it helps to identify compounds when a reference library is used.
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GC/MS + NTFD (Non-targeted Tracer Fate Detection)Stable isotope labeling experiment
Figure 2.5: Non-targeted tracer fate detection (NTFD). Stable-isotope labeled
compounds (in this case 13C) are fed to the cell culture. After a GC/MS measurement,
the NTFD algorithm automatically detects all labeled compounds and automatically
calculates mass isotopomer distributions (MIDs) for all detected compounds. Since
NTFD is non-targeted, not only MIDs for known labeled compounds (red triangle)
are calculated, but also MIDs for unknown labeled compounds (red triangles with
blue frame). Known compounds without label are shown as green triangles, unknown
compounds without label as blue triangles.
2.2 Non Targeted Tracer Fate Detection
The discovery of itaconic acid was relatively straightforward, because of its high intracel-
lular abundance in LPS stimulated macrophages compared to unstimulated macrophages.
Itaconic acid turned out to be an endpoint of an intracellular flux as a part of the mam-
malian immune response. In case of metabolic cycles or parallel pathways, however,
measuring metabolite concentrations is not sufficient to detect changes in intracellular
metabolic fluxes. Moreover, often only pathway intermediates can be measured. As
the intracellular concentrations of those pathway intermediates usually do not change
significantly, a stable isotope labeling experiment has to be performed to infer metabolic
fluxes from the labeling patterns of these intermediates (see Figure 1.11). Besides the
determination of intracellular metabolic fluxes, a stable isotope labeling experiment al-
lows one to follow the fate of a specific stable isotope labeled substrate within a given
system. Since cellular metabolism is highly complex and not yet fully understood, the
advantage of following the distribution of labeling in the metabolic network in a non-
targeted manner is clear. For example, disease specific alterations of metabolism may
differ from biochemical knowledge derived from textbooks or databases. One method for
the non-targeted detection of stable isotope labeled compounds was described by Hiller
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[Hiller et al., 2010] . In this section I will describe the implementation of this algorithm
in a stand alone software that allows to detect all stable isotope labeled compounds
downstream from a given substrate (Figure 2.5).
NTFD can be used as a discovery tool that can probe cellular metabolism in a non-
targeted way. Usually, the correct calculation of MIDs is a highly targeted process and
Figure 2.6: NTFD graphical user interface. The NTFD program provides an easy
to use graphical user interface which allows the user to import GC/MS data in netCDF
format. The NTFD program then performs automatically the compound detection and
detects all labeled compounds within the provided chromatograms. Finally, the MIDs
for those labeled compounds are calculated.
requires detailed information about the compounds of interest prior to the analysis. This
information includes either the unlabeled reference spectrum or the chemical formula for
the fragment ion of interest. In theory, one could investigate every potentially labeled
mass spectrum and compare it to the corresponding unlabeled mass spectrum in order
to detect all labeled compounds. However, this is a time consuming process and in case
of a low percentage of enrichment, almost impossible to catch by manual inspection.
For that reason, we developed the NTFD software package with a graphical user in-
terface (Figure 2.6) and made it publicly available for the metabolomics community at
http://ntfd.mit.edu. The NTFD program can import GC/MS data in netCDF format
and performs the following steps automatically:
• Compound detection and chromatographic deconvolution
• Chromatogram alignment
• Detection of labeled compounds
• Calculation of MIDs for labeled compounds
• Compound identification with a reference library
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• Export of result in a tab separated format
Chapter 2. Non-Targeted Metbolomics 32
2.3 Metabolome Of The Neuronal Cell Line LUHMES
Dopaminergic neurons are primarily found in the substantia nigra pars compacta of
the midbrain. Although they are few in numbers (usually less than 1% of the total
number of brain neurons), they play an important role in the control of multiple brain
functions such as voluntary movement and behavioral processes [Chinta and Andersen,
2005] and constitute the major source of dopamine in the mammalian central nervous
system. The progressive degeneration of dopaminergic neurons is the major hallmark
of Parkinson’s Disease (PD). PD is one of the most common neurological disorders,
affecting around 1—2% of the over 55 years old population, with differences in gender
and increased prevalence with ageing. To date, several different processes including
inflammation, oxidative stress and mitochondrial dysfunction have been hypothesized
to be the cause of this loss of dopaminergic neurons. As dopamine metabolism itself can
be a source of oxidative stress [Meiser et al., 2013], I analyzed the metabolome of the
human dopaminergic neuronal cell line LUHMES [Scholz et al., 2011]. LUHMES are
Medium
supplement:
Day0
+bFGF
Differentiation
+tetracycline+cAMP+GDNF
Day5 Day 12
Proliferation
Neuronal precursor cell Mature neuron
Figure 2.7: LUHMES differentiation. Neuronal precursor cells can be proliferated
by adding cytokine basic fibroblast growth factor (bFGF) as a medium supplement. In
absence of bFGF these neuronal precursor cells can be differentiated to mature neurons
by adding tetracycline, dibutyryl cAMP (cAMP), and glial cell derived neurotrophic
factor (GDNF) to the medium.
human mesencephalic cells conditionally immortalized with a v-myc retroviral vector
to ensure continuous proliferation. Inactivation of this vector with tetracycline allows
differentiation into mature neurons within 5 to 12 days (Figure 2.7).
2.3.1 Oxygen Level
It has been shown previously that differentiation of neuronal precursor cells to dopamin-
ergic neurons is enhanced under low oxygen conditions [Studer et al., 2000]. Since the
in vivo oxygen level in mammalian brains is as low as 1% to 5% [Studer et al., 2000],
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I intended to test whether the metabolome of proliferating vs differentiated LUHMES
cells is affected by the oxygen level. For that reason, I cultured proliferating LUHMES
cells at a low oxygen level (5%) and at standard cell culture conditions (20%). Likewise,
I differentiated the LUHMES cells at 5% and 20% oxygen. After nine days I extracted
the intracellular metabolites and subsequently measured them with GC/MS (analytical
details can be found in ??).
After GC/MS measurement, I applied the ICBM algorithm to match compounds across
the four conditions. Figure 2.8 depicts the principal component analysis (PCA) of this
experiment. The metabolomes of proliferating and differentiated LUHMES cells are well
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Figure 2.8: PCA of differentiated and proliferating LUHMES cells at 5%
and 20% oxygen
separated, so are the metabolomes of differentiated LUHMES cells at 5% and 20% oxy-
gen. However, the metabolome of proliferating LUHMES cells cannot be distinguished
based on the two oxygen levels when all four conditions are considered.
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At the metabolome level, there is a difference between LUHMES cells differentiated at
5% oxygen and LUHMES cells differentiated at 20% oxygen. To further study the dif-
ferences in the metabolome of proliferating and differentiated LUHMES cells at different
oxygen levels, I performed an analysis of variance (ANOVA) to detect all significantly
(Bonferroni corrected p-value < 0.0003 ) changed metabolites. Overall, I was able to
detect 5 significantly changed metabolites. The corresponding bar plots are depicted
in Figure 2.9. Interestingly, lactic acid levels are higher in differentiated LUHMES cell
compared to proliferating LUHMES cells. This is in contrast to the observation that
proliferating cells mainly rely on aerobic glycolysis to produce adenosine 5-triphosphate
(ATP) [Vander Heiden et al., 2009]. However, I am presenting intracellular metabolite
levels here and lactic acid is usually excreted from the cell. The lactic acid levels in dif-
ferentiated LUHMES cells at 5% oxygen are higher compared to differentiated LUHMES
cells at 20% oxygen, because of the absence of O2 to fuel mitochondrial oxidative phos-
phorylation. An interesting difference between differentiated LUHMES cells at the two
oxygen levels is the increased abundance of γ-aminobutyric acid (GABA) at 5% oxy-
gen. GABA is the major inhibitory neurotransmitter in the mammalian central nervous
system. Recently it has been shown that dopaminergic neurons can release GABA via
the vesicular monoamine transporter VMAT2, which is also the vesicular transporter
for dopamine [Tritsch et al., 2012]. This underlines the fact that for dopaminergic cell
culture models a low oxygen level should be applied to better reflect conditions in the
brain.
In conclusion, this experiment showed that the metabolome of differentiated LUHMES
cells at 5% and 20% oxygen is clearly different. These differences do not only originate
from metabolites that have been shown before to be affected by hypoxic conditions,
such as lactic acid or citric acid [Vander Heiden et al., 2009]. For example, GABA is
not directly linked to increased aerobic glycolysis. Nevertheless, it is increased in differ-
entiated LUHMES cell at 5% oxygen. This suggests that indeed the differentiation of
dopaminergic neurons is enhanced at low oxygen levels.
2.3.2 Dopamine Metabolism
Although LUHMES should be dopamine producing cells [Scholz et al., 2011], I was not
able to detect dopamine in any of the four conditions. To estimate our analytical sen-
sitivity for dopamine by GC/MS, I determined the limit of detection with a dilution
series of dopamine standards, starting with 1.5mg/mL. As a result I calculated that we
are able to detect dopamine concentrations down to the nanomolar range in full scan
mode and down to the picomolar range in single ion mode. To further test if the ap-
plied extraction protocol is suitable for dopamine detection, we extracted and measured
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Figure 2.9: Bar plots for selected metabolites of proliferating and differen-
tiated LUHMES cells at 5% and 20% oxygen.
mouse brain extracts. Although a mouse brain contains only a few thousand dopaminer-
gic neurons [German and Manaye, 1993], a clear dopamine peak was detectable (Figure
2.10). Together with Dr Johannes Meiser, we tested if the most important enzyme of
dopamine synthesis, tyrosine hydroxylase (TH), is present in differentiated LUHMES
cells. The Western blot for TH depicted in Figure 2.11 was performed within our group
by Dr. Johannes Meiser. Based on the Western Blot, TH protein is present in differen-
tiated LUHMES cells at 2% and 20% oxygen, but not in proliferating LUHMES cells.
It is important to note that the TH protein abundance is much higher at 2% oxygen
compared to 20% oxygen. This result further endorses the fact that neuronal differenti-
ation is enhanced under low oxygen conditions. In conclusion, we have a highly sensitive
method for dopamine detection (picomolar), we are able to detect dopamine in mouse
brain extracts, and TH is present in differentiated LUHMES cells, but I was not able to
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Figure 2.10: GC/MS measurement of mouse midbrain extract. A part of the
total ion chromatogram (TIC) is shown in the upper part. Dopamine 4TMS elutes
at 28.38 minutes. The lower part shows the mass spectrum of Dopamine 4TMS. The
measured spectrum is shown in blue in the positive direction and the library spectrum
is shown in red in the negative direction.
Diff. + + -
O2 2% 20% 20%
TH
GAPDH
Figure 2.11: Tyrosine hydroxylase abundance. This Western blot was kindly
provided by Dr. Johannes Meiser.
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detect dopamine in differentiated LUHMES cells. This result suggests that the presence
of TH alone is not sufficient to classify cells as dopamine producing cells and underlines
the importance of metabolomics to study cellular phenotypes.
Chapter 3
Targeted Metabolomics
Methodologies
This chapter covers a manuscript about a methodology for the determination of chemical
formulas and retained atoms for mass spectral fragment ions. The main results are
summarized with respective cross references to the manuscript given. For methodological
details, please consult the corresponding manuscript [Wegner et al., 2014].
Wegner, A.; Weindl, D.; Ja¨ger, C.; Sapcariu, S. C.; Dong, X.;
Stephanopoulos, G.; Hiller, K.
Analytical chemistry
3.1 Fragment Formula Calculator
As stated in section 1.1.3, non-targeted methodologies are of great importance, but
they cannot replace targeted approaches. For example, MIDs are of high importance
for stable isotope labeling experiments and can be calculated in a non-targeted way
with the NTFD algorithm. However, to make biological sense out of MIDs, detailed
information about the underlying fragment ions are necessary. Specifically, the structural
formulas for fragments ions are essential to pull out biological information of MIDs. This
information can be obtained only in a targeted way and requires the structural formula
of the molecular (Figure 3.1). For example, 13C-MFA relies on exact knowledge of
the position of the label in order to determine intracellular fluxes from MIDs using a
nonlinear least-squares parameter estimation approach (see Section 1.3). In this process,
MIDs obtained from a stable isotope labeling experiment help to constrain the fluxes in
38
Chapter 3. FFC 39
I 0obs I 1obs I 2
obs
I 3obs
I 4obs
Labeled mass spectrum of 
fragment ion at m/z 190 of 
Alanine 3 TMS
( I 0obsI 1obsI 2obsI 3obsI 4obs)=(M00 0 0M01 M10 0M02 M11 M200 M12 M210 0 M22)∗(f0f1f2)
C7H20NOSi2
M0 M1 M2 M3
1
0.2
0.4
0.6
0.8
C
O
O CH3CNSiH3C
H Si
CH3
CH3CH3
CH3
CH3
C
O
O CH3CNSiH3C
H Si
CH3
CH3CH3
CH3
CH3
A)
B)
C) D)
E)
F)
Figure 3.1: Importance of targeted methodologies. A) The labeled mass spec-
trum for the fragment ion at m/z 190 of Alanine is shown. B) In order to calculate
MIDs, either the chemical formula or the unlabeled reference spectra must be avail-
able. C) Set-up of the linear equation system. Note that this is also possible in a
non-targeted methodology when the unlabeled reference spectrum is applied. D) MIDs
can be calculated in a target and non-targeted way. E) The retained carbon atoms can
be only determined if the structural formula of the molecular ion is available. Hence
this can only be done in a targeted way. F) The calculated MIDs in combination with
the retained carbon atoms can applied in 13C-MFA.
a given system. In particular, MIDs for fragment ions containing different carbon atoms
are of high interest, since they can carry different flux information. Therefore it is crucial
to identify the structural formulas for mass spectral fragment ions. Since 13C-MFA is
based on carbon labeling, it is sufficient to identify the retained carbon atoms. However,
the process of assigning a chemical formula and retained atoms to mass spectral ions
is non-trivial and time-consuming, even for an expert. For that reason, I developed
an algorithm that can determine the chemical formulas and the retained atoms for
mass spectral fragment ions. Generally, there are two ways to determine the retained
atoms of a fragment ion: a rule-based in silico prediction or a combinatorial approach
based on a systematic bond cleavage. Rule-based algorithms rely on fragmentation
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mechanisms derived from molecules where the fragmentation is known, assuming that
similar structures will fragment the same way. However, small changes in structure can
lead to a significantly different fragmentation mechanism. Furthermore, the rule-based
approach fails for molecules where no similar fragmentation mechanism is known. Here,
I present a method to determine the chemical formulas and the retained atoms for mass
spectral fragment ions without a priori knowledge about the fragmentation mechanisms,
taking advantage of the combinatorial aspect of the problem. For that, I will apply the
molecule’s graph-theoretical representation to model the fragmentation.
3.1.1 Algorithm
I model a molecule as an undirected, connected and labeled graph G = (V,E, fV A, fV B,
fV C , fED), where V is the set of vertices corresponding to the atoms and E is the set of
undirected edges corresponding to the bonds between the atoms. The function fV A : V
→ A assigns each atom an element (e.g. carbon, hydrogen, etc.), fV B : V → B assigns
each atom an index and fV C : V → C assigns each atom the atomic mass according
to the chemical element. The function fED : V × V → D assigns each bond an order
(single, double, triple). The mass of the molecular ion corresponds to the sum of the
masses of all vertices:
W (G) =
∑
v∈V
fV C(v) (3.1)
The underlying idea of this algorithm is that the fragmentation process usually only
breaks a few bonds within the molecule. This can be simulated by removing a defined
number of edges within the molecular graph. In terms of graph theory this means to
induce a cut of a certain size in in the graph. This can leave the graph G disconnected.
The resulting connected components C = {C1, ..., Cn} of the subgraph H each have a
molecular mass:
W (Ci) =
∑
v∈V (Ci)
fV C(v) (3.2)
Since the mass m of the fragment ion is determined by mass-spectrometry, the chemical
formula of this fragment ion corresponds to a combination of connected components of
H which molecular masses W (Ci) sum up to m. Figure 3.2 illustrates this process. The
resulting subgraph (representing the chemical composition), which can be composed of
several connected components, does not necessarily represent the chemical structure,
because the formation of new bonds (e.g. fragmentation rule 4 described in Section
1.1.1.2) is not modeled. However, the number and position of atoms of the intact
compound retained in this fragment ion is uncovered.
So far, I have relied on the assumption that the correct edges are deleted from the graph.
There are two unknowns, the number and the position of edges to be deleted. To define
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Figure 3.2: Overview of FFC algorithm. (A) As input FFC needs the 2D structure
of the compound together with the mass spectrum of the ion of interest. In this example,
I present the molecule N,O-bis-(trimethylsilyl)-glycine (219 Da) and the fragment ion
at mass 176. (B) The 2D structure is first converted into a molecular graph. The
graph contains 34 vertices and 33 edges. Then all combinations of edge sets of a
certain size (in this case 3) are consecutively deleted from the graph, resulting in 5456
disconnected graphs, one for each edge set deleted. The number of resulting subgraphs
can be calculated with the binomial coefficient where n corresponds to the number of
edges and k corresponds to the cut size (Equation 3.3). For simplification, only the
edge set leading to the correct fragmentation is shown here. (C) For each disconnected
graph the connected components are determined. For every combination of connected
components where the molecular masses sum up to the mass of the fragment ion, the
atoms of these components are combined to build up a candidate formula. In this
example, the connected components shown in green and light blue with the masses 87
and 89 sum up to the target mass of 176. The candidate formula is then C6H18NO2Si2,
which is indeed the correct formula for this fragment ion. In addition to the chemical
formula, the algorithm also yields positional information about the fate of specific
atoms. For example, the carboxyl carbon of the original glycine molecule is lost in this
fragment ion. (D) Based on the candidate formula the theoretical mass spectrum is
predicted and a spectrum similarity score to the measured spectrum based on the dot
product is calculated. This is of special importance if more than one sum formula can
be derived for the target mass.
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the minimal number of edges to delete from the graph (cut size), necessary to model
the fragmentation, it is mandatory to take the fragmentation rules (as stated in Section
1.1.1.2) into consideration. Fragmentation types 1-3 cleave one bond without forming
new σ-bonds, 4 and 5 cleave one bond while forming a new one, 6 cleaves two bonds
while forming a new one. Therefore, to describe an α-cleavage or a σ-ionization, clearly
a cut size of one is sufficient. To simulate a simple elimination or a rearrangement, which
is equivalent to deleting one edge in the graph, a cut size of one is also necessary. For the
combination of a more complex rearrangement and an α-cleavage, a cut size of three is
necessary. To capture both the single and the combined fragmentations, the algorithm
is designed to work with a defined maximum cut size. The cut size starts at one and
subsequently increases until it reaches the defined maximum cut size.
One way to find the correct edges to delete from the graph is to select those edges that
are most likely to break. For example, low-energy bonds can be assumed to break more
easily. Although this is correct, additional rules are needed to describe rearrangements.
Another more straightforward way is to delete all possible combinations of edges of a
certain cut size. Certainly this includes the correct edges, but at the same time increases
the number of possible results enormously. If the number of edges is given by n and
the cut size by k, then the number of k distinct elements of n is given by the binomial
coefficient: (
n
k
)
=
n!
k! · (n− k)! (3.3)
For example, the graph of the molecule N,O-bis-(trimethylsilyl)-glycine with the molec-
ular formula C8H21NO2Si2 has 33 edges. The number of possible distinct edge sets to
delete for a cut size of 3 is then 5456.
To find the correct edges, the resulting fragment formulas for each of these possibilities
have to be ranked according to a score. At best, this score is linked to the measured
mass spectrum. One elegant way to do so is to predict the theoretical mass spectrum
of the determined fragment formula and calculate a spectrum similarity score to the
measured mass spectrum of this fragment ion. A mass spectrum can be theoretically
predicted by using the natural stable isotopic distribution of elements and statistical
theory [Fernandez et al., 1996]. For elements that only have one naturally occurring
stable isotope of significant abundance, the distribution of isotopes can be predicted by
a binomial distribution:
mi =
n!
i! · (n− i)! · p
n−i
0 · pi1 (3.4)
where n is the total number of atoms, i the number of atoms containing the heavier
isotope (e.g. 13C), p0 the natural abundance of the lighter isotope (e.g. p(
12C)=0.989)
and p1 the natural abundance of the heavier isotope (e.g. p(
13C)=0.01). In case an
element has several natural occurring isotopes the distribution of those isotopes within
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a molecule can be predicted by a multinomial distribution:
mi =
n!
a1! · a2! · ... · ak! · p
a0
0 · pa11 · ... · pakk (3.5)
where n is the total number of atoms, a0 to ak the number of atoms containing the
respective isotope and p0 to pk the natural abundances of those isotopes.
3.1.1.1 Reducing Algorithmic Complexity
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Figure 3.3: Graph representation of N,O-bis-(trimethylsilyl)-glycine. The
graph contains 33 edges. For a cut size of three the number of distinct edge pairs to
delete is 5456. To reduce the number of distinct edge pairs, non backbone edges (edges
that are not connected to at least one backbone atom) are grouped based on their loss
pattern. For example, edges shown in red are grouped together because their removal
leads to the loss of one hydrogen. The group of edges shown in blue lead to the loss of
a methyl group when one of these edges is removed. The group of edges shown in green
lead to the loss of a TMS group when one of these edges is removed. After reduction
to relevant backbone edges, the graph now contains only 7 distinct edge groups (as
illustrated by the numbers above the edges) which reduces the number of distinct edge
sets of size 3 from 5456 to 35.
For GC/MS, compounds are usually derivatized prior to analysis. For example, hydro-
gens in polar functional groups can be replaced with a trimethylsilyl (TMS) or tert-
butyldimethylsilyl (TBDMS) group (see Section 1.1.1.3). This makes compounds more
volatile and less reactive, but at the same time increases the computational complex-
ity of finding the correct chemical formula of a fragment ion. In case of stable isotope
labeling experiments, the interest lies normally only in labeling patterns for atoms of
the original (underivatized) molecule. As a consequence, the information obtained from
the loss of atoms originating from the derivatization agent used is often redundant. For
example, when TMS derivatization is used, a [M-15]+ fragment is often present in the
mass spectrum, originating from the loss of a methyl group from the derivatized part of
the molecule. Depending on the number of TMS groups within the molecule, there are
several possibilities for the position of the lost methyl group. Concerning the calculation
of chemical formulas, however, the position of this methyl group is not relevant and com-
putational time can thus be saved. For that reason, we divide the molecular graph into
atoms belonging to the original molecule (backbone atoms) and atoms originating from
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the derivatization agent used. Subsequently, non backbone edges (edges that are not
connected to at least one backbone atom) are grouped based on the atoms that would
be lost if this edge is deleted (Figure 3.3). For example, all edges are grouped together
where their removal would lead to the loss of one hydrogen. This reduces the number
of distinct edges significantly, thereby decreasing the combinatorial complexity for the
problem of finding the correct chemical formula. Additionally, this allows the user to
follow the fate of specific atoms in the molecular ion by selecting them as backbone
atoms.
Another advantage which makes the proposed algorithm capable of modeling rearrange-
ments is the use of connected components. Fragment ions resulting from a rearrangement
reaction are often composed of two or more disjoint substructures of the molecular ion.
Identifying these substructures is computationally challenging, as their number grows
enormously with the number of atoms. However, in our algorithm the number of these
substructures is limited by the number of connected components within the molecular
graph, making the proposed algorithm also applicable for larger molecules.
3.1.1.2 Constraining The Result Set
One major advantage of the FFC program compared to commercial softwares such as
ACD/MS Fragmenter or Mass Frontier is that it is able to incorporate stable isotope
labeled spectra in the analysis. In most cases multiple candidate formulas are available
for one fragment ion and it is not immediately clear which of those formulas is the correct
one. In these cases, a stable isotope labeled spectra of the compound of interest can help
to remove wrong candidate formulas from the the result set. For that, the FFC program
assigns each atom within the molecule a binary state: 1 means this atom is present in
this fragment ion and 0 means it is cleaved off. Consequently, each candidate formulas is
described by a set of bits depending on the atoms present in this candidate formula. In
order to include the labeled spectra in the analysis, the FFC program uses a second bit
(labeled bit set) set to describe the applied stable isotope tracer. This bit set describes
the labeling state of each atom within the molecule: 1 means this atom is labeled and
0 means the atom is unlabeled. For example, 13C3 β-Alanine has 3 labeled carbon
atoms. This means the bits corresponding to these three carbon atoms would be set to
1 and the bits corresponding to the remaining atoms to 0 (Figure 3.4). Subsequently,
each candidate formula’s bit set is combined with the labeled bit set through a logical
conjunction. The resulting bit set defines exactly how many labeled atoms are present
in this candidate formula and can be easily calculated by counting the number of 1’s
in this bit set. The number of labeled atoms can then be compared to the measured
labeled spectrum. For that, the FFC program automatically calculates the MIDs for this
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Figure 3.4: Constraining the result set. The FFC program assigns each atom
a binary state: : 1 means this atom is present in this fragment ion and 0 means it is
cleaved off. The bit set for the molecular ion of β-Alanine 3TMS is shown in the upper
left. The corresponding bit set for 13C3 β-Alanine 3TMS is shown in the upper right.
For the fragment ion at m/z 290 the FFC program calculates three possible solutions:
one with all three carbons of the β-Alanine still present and two with one carbon atom
lost. In order to get the number of labeled atoms present in the candidate formulas,
the FFC program combines each candidate formula’s bit set is with the labeled bit set
through a logical conjunction. This number can then be compared to the calculated
MIDs. In this case, all three carbons of β-Alanine are still present in the fragment ion
at m/z 290 and solutions one and three are excluded from the result set.
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fragment ion. However, for an accurate MID calculation a correction matrix is needed
to solve the linear equation system [Lee et al., 1991]. This correction matrix can either
be setup with the chemical formula or the unlabeled reference spectrum of the fragment
ion (see Section 1.2.1). Since the chemical formula is the information the FFC program
intends to calculate, the software applies the unlabeled reference spectrum to set-up the
correction matrix. Finally, all candidate formulas that contradict the MIDs are then
automatically excluded from the result set.
The FFC program can calculate MIDs for a wide range of tracers (e.g 2H, 15N, 13C or
18O). In case of d9-MSTFA, however, the number of deuterium labeled atoms can easily
grow above twenty, which can complicate the calculation of MIDs. For that reason, the
FFC program does not calculate MIDs for d9-MSTFA labeled spectra, but calculates
the number of 2H atoms as follows:
1. Calculate the maximum number of 2H labeled atoms possible:
maxL = #TMS-groups · 9
2. Find all isotope clusters in the d9-MSTFA labeled spectrum within the following
range:
m/z value of the monoisotopic peak of the fragment ion of interest (corresponds
to 0 2H) + maxL (corresponds to the maximum number of 2H)
3. Calculate a spectrum similarity score (e.g with the ICBM algorithm) between all
isotope clusters determined in the previous step and the fragment ion of interest
4. Select the isotope cluster with the highest spectrum similarity score (maxS)
5. Calculate the number of 2H labeled atoms by subtracting the m/z value of the
monoisotopic peak of maxS from m/z value of the monoisotopic peak of the frag-
ment ion of interest
3.1.2 Software Package
Further on I implemented the algorithm in the stand alone software package fragment
formula calculator (FFC). Figure 3.5 depicts the graphical user interface of the FFC
program. The FFC program is optimized to determine chemical formulas for GC/MS
fragment ions.
The input to the program consists of the 2D structure of the compound together with
the measured mass spectrum. This data can be loaded directly by the user; a MOL
file for the structure and a csv file for the mass spectrum. Additionally, FFC allows
the user to import a library in NIST format to an SQLite database which then can
Chapter 3. FFC 47
Figure 3.5: FFC graphical user interface. The window (in the upper part of the
main interface) displays the loaded spectrum. The window (in the bottom left of the
main interface) contains the compound of interest for fragment calculation shown in
the the “Compound Info” tab. The “Result” tab contains the calculated formulas for
the compound of interest at the corresponding sized fragment. If a spectrum from a
stable isotope labeling experiment was added to the analysis, the “MIDs” tab shows the
calculated MIDs for the current selected fragment. The window (in the bottom right
of the main interface) displays the chemical structure of the compound of interest. If a
result row is selected from the “Result” tab, this window visualizes the fragmentation
by highlighting lost atoms with a square and broken bonds with a dashed line.
be queried for a chemical formula or a compound’s name (Figure 3.6). Mass spectral
fragment ions are detected automatically based on the mass spectrum [Wegner et al.,
2013]. The structure is visualized based on the atom coordinates defined in the MOL
file. For clarity, atoms are colored according to the CPK scheme and hydrogens are
hidden. Candidate formulas and the corresponding atoms within the molecule can be
calculated by pressing the “Start Calculation” button. By default, all atoms within
the molecule are considered as backbone atoms, but this can be manually corrected for
derivatized compounds. The program generates a list of possible hits which are shown
in the “Result tab”. This “Result tab” includes the following entries:
• Chemical formula
• Spectrum similarity score of each predicted mass spectrum to the measured mass
spectrum based on the dot product [Stein and Scott, 1994]
• List of backbone atoms present in each candidate formula
• The average and maximum deviation from each measured to the theoretical (pre-
dicted) mass spectrum
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• The number of broken bonds
• Even electron ion (yes/no)
Figure 3.6: FFC library search interface. The FFC program allows the user to
import a library in NIST format to an SQLite database which then can be queried for
a chemical formula or a compound’s name
3.2 Fragment Formula Repository
As stated in the previous section, the chemical formula in combination with positional
information of atoms present in a fragment ion is of high importance to extract biological
information out of MIDs. For that reason, I applied the FFC program to determine the
chemical formulas and carbon atom composition for a wide range of TMS and TBDMS
derivatized compounds of central carbon metabolism.
As mentioned in Section 3.1, the use of stable isotope labeled reference standards can
greatly improve the predictive capabilities of the FFC algorithm. However, these la-
beled reference compounds are very expensive. That is why we generated fully labeled
reference spectra in our lab. For that, we used yeast grown on U-13C D-glucose as the
only carbon source (Figure 3.7). As a result we generated a comprehensive set of fully
labeled reference spectra for TMS, d9-TMS, and TBDMS derivatized compounds (Fig-
ure 3.8). Later, I used the unlabeled and fully labeled mass spectra as input for the
FFC algorithm and determined the chemical formulas and retained carbon atoms of 160
fragment ions. The chemical formulas for the TMS derivatized compounds can be found
in Table 3.1 and for the TBDMS derivatized compounds in Table 3.2.
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Figure 3.7: Overview yeast culture. Yeast was cultivated on minimal medium
with U-13C D-glucose as the only carbon source. To obtain fully labeled extracts three
overnight cultivations were applied before cell harvesting.
13C
MSTFA
TBDMS
MSTFA
TBDMS
d9-MSTFA
Figure 3.8: Overview yeast measurements. Labeled and unlabeled yeast extracts
were derivatized with MSTFA and TBDMS and measured with GC/MS. The unlabeled
extracts were additional derivatized with d9-TMS.
Chapter 3. FFC 50
3.2.1 TMS Derivatized Fragment Ions
The retained carbon atoms of all compounds in Table 3.1 can be found in [Wegner et al.,
2014]. Atoms that were lost in a fragment ion are shown in red and retained atoms in
black.
Table 3.1: TMS Derivatized Fragment Ions
Compound m/z m/z 13C m/z d9-TMS Formula
Adenine 2TMS 279 284 297 C11H21N5Si2
264 269 279 C10H18N5Si2
206 211 215 C8H12N5Si
Alanine 2TMS 233 - - C9H23NO2Si2
218 220, 221 233, 236 C8H20NO2Si2
190 192 205 C7H20NOSi2
116 118 125 C5H14NSi
Aspartic acid 2TMS 277 281 295 C10H23NO4Si2
262 266 277 C9H20NO4Si2
234 237 249 C8H20NO3Si2
220 222 235 C7H18NO3Si2
160 163 169 C6H14N1O2Si
Aspartic acid 3TMS 349 354 376 C13H31NO4Si3
334 338 358 C12H28NO4Si3
306 309 330 C11H28NO3Si3
292 294 316 C10H26NO3Si3
232 235 250 C9H22NO2Si2
218 220 236 C8H20NO2Si2
β-Alanine 3TMS 305 - - C12H31NO2Si3
290 - 314 C11H28NO2Si3
248 - 272 C9H26NOSi3
232 - 250 C9H22NO2Si2
174 - 192 C7H20NSi
86 - 92 C3H6OSi
Citric acid 4TMS 480 - - C18H40O7Si4
465 471 498 C17H37O7Si4
375 381 399 C14H27O6Si3
363 368 390 C14H31O5Si3
347 352 371 C13H27O5Si3
273 278 291 C11H21O4Si2
Continued on next page
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Table 3.1 – Continued from previous page
Compound m/z m/z 13C m/z d9-TMS Formula
3-phosphoglycerate 4TMS 474 - - C15H39O7PSi4
459 462 492 C14H36O7PSi4
387 387 423 C12H36O4PSi4
357 359 384 C11H30O5PSi3
315 315 342 C9H28O4PSi3
299 299 323 C8H24O4PSi3
Glycerol-3-phosphate 4TMS 460 - - C15H41O6PSi4
445 448 478 C14H38O6PSi4
387 387 423 C12H36O4PSi4
357 359 384 C11H30O5PSi3
341 343 365 C10H26O5PSi3
299 299 323 C8H24O4PSi3
Glutamic acid 3TMS 363 368 390 C14H33NO4Si3
348 353 372 C13H30NO4Si3
320 324 344 C12H30NO3Si3
246 250 264 C10H24NO2Si2
230 234 245 C9H20NO2Si2
Glutamine 3TMS 362 367 389 C14H34N2O3Si3
347 352 371 C13H31N2O3Si3
273 278 291 C11H25N2O2Si2
245 249 263 C10H25N2O1Si2
Glycerol 3TMS 308 - - C12H32O3Si3
293 296 317 C11H29O3Si3
218 221 236 C9H22O2Si2
205 207 223 C8H21O2Si2
Glycine 3TMS 291 293 - C11H29NO2Si3
276 278 300 C10H26NO2Si3
248 249 274 C9H26NOSi3
174 175 192 C7H20NSi2
Isoleucine 2TMS 275 - - C12H29NO2Si2
260 265, 266 275, 278 C11H26NO2Si2
232 237 247 C10H26NOSi2
218 220 236 C8H20NO2Si2
158 163 167 C8H20NSi
Leucine 2TMS 275 - - C12H29NO2Si2
260 265, 266 275, 278 C11H26NO2Si2
Continued on next page
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Table 3.1 – Continued from previous page
Compound m/z m/z 13C m/z d9-TMS Formula
232 237 247 C10H26NOSi2
218 220 236 C8H20NO2Si2
158 163 167 C8H20NSi
Lysine 3TMS 362 368 389 C15H38N2O2Si3
347 353 371 C14H35N2O2Si3
200 206 209 C9H18NO2Si
174 175 192 C7H20NSi2
156 161 165 C8H18NSi
Lysine 4TMS 434 440 470 C18H46N2O2Si4
419 425 452 C17H43N2O2Si4
391 396 324 C16H43N2OSi4
317 322 344 C14H37N2Si3
174 175 192 C17H20NSi2
Malic acid 3TMS 350 354 377 C13H30O5Si3
335 339 359 C12H27O5Si3
307 311 331 C11H27NO4Si3
245 249 260 C9H17O4Si2
233 236 251 C9H21O3Si2
Phenylalanine 2TMS 309 - - C15H27NO2Si2
294 303 309 C14H24NO2Si2
266 274 281 C13H24NOSi2
218 220 236 C8H20NO2Si2
192 200 201 C11H18NSi
Proline 2TMS 259 - - C11H25NO2Si2
244 249 259 C10H22NO2Si2
216 220 231 C9H22NOSi2
142 146 151 C7H16NSi
Serine 3TMS 321 - - C12H31NO3Si3
306 309 330 C11H28NO3Si3
278 280 302 C10H28NO2Si3
218 220 236 C8H20NO2Si2
204 206 222 C8H22NOSi2
188 190 203 C7H18NOSi2
Succinic acid 2TMS 262 266 280 C10H22O4Si2
247 251 262 C9H19O4Si2
Continued on next page
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Table 3.1 – Continued from previous page
Compound m/z m/z 13C m/z d9-TMS Formula
172 176 181 C7H12O3Si
Threonine 3TMS 335 - - C13H33NO3Si3
320 324 344 C12H30NO3Si3
218 221 236 C9H24NOSi
Tyrosine 2TMS 325 - - C15H27NO3Si2
310 319 325 C14H24NO3Si2
282 290 297 C13H24NO2Si2
208 216 217 C11H18NOSi
192 200 198 C10H14NOSi
Tyrosine 3TMS 397 - - C18H35NO3Si3
382 391 406 C17H32NO3Si3
354 362 378 C16H32NO2Si3
280 288 298 C14H26NOSi2
218 220 236 C8H20NO2Si2
Uracil 2TMS 256 260 284 C10H20N2O2Si2
241 245 256 C9H17N2O2Si2
Valine 2TMS 261 - - C11H27NO2Si2
246 251 261 C10H24NO2Si2
218 220, 222 233 236 C9H24NOSi2
3.2.2 TBDMS Derivatized Fragment Ions
The retained carbon atoms of all compounds in Table 3.2 can be found [Wegner et al.,
2014]. Atoms that were lost in a fragment ion are shown in red and retained atoms in
black.
Table 3.2: TBDMS Derivatized Fragment Ions
Compound m/z m/z 13C Formula
Alanine 2TBDMS 317 - C15H35NO2Si2
302 305,306 C14H32NO2Si2
274 276 C13H32NOSi2
260 263 C11H26NO2Si2
232 234 C10H26NOSi2
Continued on next page
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Table 3.2 – Continued from previous page
Compound m/z m/z 13C Formula
Aspartic acid 3TBDMS 475 - C22H49NO4Si3
460 464 C21H46NO4Si3
418 422 C18H40NO4Si3
390 393 C17H40NO3Si3
376 378 C16H38NO3Si3
316 319 C15H34NO2Si2
302 304 C14H32NO2Si2
Citric acid 4TBDMS 648 - C30H64O7Si4
633 639 C29H61O7Si4
501 507 C23H45O6Si3
459 465 C20H39O6Si3
Fumaric acid 2TBDMS 344 - C16H32O4Si2
329 333 C15H29O4Si2
287 291 C11H20O4Si2
γ-Aminobutyric acid 2TBDMS 331 - C16H37NO2Si2
316 320 C15H34NO2Si2
274 278 C12H28NO2Si2
Glutamine 3TBDMS 488 - C23H52N2O3Si3
473 478 C22H49N2O3Si3
431 436 C19H53N2O3Si3
357 362 C17H37N2O2Si2
329 333 C16H37N2OSi2
Glutamic acid 3TBDMS 489 - C23H51NO4Si3
474 479 C22H48NO4Si3
432 437 C19H42NO4Si3
358 363 C17H36NO3Si2
330 334 C16H36NO2Si2
272 276 C12H26NO2Si2
Histidine 3TBDMS 497 - C24H51N3O2Si3
482 488 C23H48N3O2Si3
440 446 C20H42N3O2Si3
412 417 C19H42N3OSi3
280 285 C14H28N2Si2
Isoleucine 2TBDMS 359 - C18H41NO2Si2
302 304,308 C14H32NO2Si2
274 279 C13H32NOSi2
Continued on next page
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Table 3.2 – Continued from previous page
Compound m/z m/z 13C Formula
200 205 C11H26NSi
Leucine 2TBDMS 359 - C18H41NO2Si2
302 304,308 C14H32NO2Si2
274 279 C13H32NOSi2
200 205 C11H26NSi
Lysine 3TBDMS 488 - C24H56N2O2Si3
473 479 C23H53N2O2Si3
431 437 C20H47N2O2Si3
329 334 C17H41N2Si2
Malic acid 3TBDMS 476 - C22H48O5Si3
461 465 C21H45O5Si3
419 423 C18H39O5Si3
391 394 C17H39O4Si3
375 378 C17H39O3Si3
287 291 C12H23O4Si2
Ornithine 3TBDMS 474 - C23H54N2O2Si3
459 464 C22H51N2O2Si3
417 422 C19H45N2O2Si3
Serine 3TBDMS 447 - C21H49NO3Si3
432 435 C20H46NO3Si3
404 406 C19H46NO2Si3
390 393 C17H40NO3Si3
362 364 C16H40NO2Si3
302 304 C14H32NO2Si2
288 290 C14H34NOSi2
230 232 C10H24NOSi2
Succinic acid 2TBDMS 346 - C16H34O4Si2
331 335 C15H31O4Si2
289 293 C12H25O4Si2
215 219 C10H19O3Si
Tyrosine 3TBDMS 523 - C27H53NO3Si3
508 517 C26H50NO3Si3
466 475 C23H44NO3Si3
438 346 C22H44NO2Si3
364 372 C20H38NOSi2
Continued on next page
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Table 3.2 – Continued from previous page
Compound m/z m/z 13C Formula
302 304 C14H32NO2Si2
Valine 2TBDMS 345 - C17H39NO2Si2
302 304, 306 C14H32NO2Si2
288 293 C13H30NO2Si2
260 264 C12H30NOSi2
Chapter 4
Conclusion
The motivation for this thesis was to develop and apply computational mass spectrometry-
based metabolomics techniques that allow to extract more biological information out
of metabolomics data. First, I presented a spectrum matching algorithm that is es-
pecially suited to match compounds across different chromatograms in a non-targeted
metabolomics experiment. In the context of diseases, non-targeted metabolomics method-
ologies have recently become more important, because cellular metabolism may be per-
turbed in a way that deviates from classical biochemical textbook knowledge. In this
light, the ICBM algorithm can help to identify disease specific biomarkers with a higher
sensitivity or can help to pinpoint targets for possible new drug treatments.
Second, I applied the ICBM algorithm to study the cellular phenotype of the human
neuronal cell line LUHMES under different oxygen conditions. Although LUHMES cells
should be dopamine producing and the rate limiting enzyme tyrosine hydroxylase (TH)
was present in the cells, I was not able to detect dopamine in either of the two oxygen
conditions. This result underlines the importance of metabolomics to study cellular
phenotypes.
Third, I presented the FFC algorithm which can help to extract more biological infor-
mation out of stable isotope labeling experiments. Electron ionization (EI) based mass
spectrometry leads to complex mass spectra, caused by the fragmentation of the ana-
lyzed compound. The analysis of fragment ions, which contain only specific parts of the
original molecule, can provide valuable information on the positional isotopic enrichment
within the molecule of interest. The FFC algorithm can calculate chemical formulas and
retained atoms of these mass spectral fragment ions. This information is of high interest
for 13C-MFA, because it provides additional constraints for the parameter fitting. Specif-
ically, fragment ions containing different carbon atoms are of high interest, since they
can carry different flux information. The FFC algorithm can complement non-targeted
stable isotope-assisted methodologies. For example, the NTFD algorithm provided the
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means to discover unanticipated metabolites and pathways related to specific diseases,
but this information can be used only in 13C-MFA if the retained carbon atoms for the
fragment ion of interest are known. As such, the FFC and NTFD algorithms can help
to increase the size of the metabolic network that can be profiled for 13C-MFA.
Fourth, I applied the FFC algorithm to determine the chemical formulas and retained
carbon atoms of 160 mass spectral fragment ions of central carbon metabolism. This
fragment ion repository will facilitate the use of 13C-MFA to study changes in intracel-
lular fluxes. In particular, 13C-MFA can give new insights in disease specific fluxes, as
well as their regulation in central biological pathways.
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